The egg-PC-liposome-based siRNA formulation was also successful in the containment of the COX-2 enzyme in the cancer cells, although less efficiently than the subtilosome-based siRNA formulation (subtilosome siRNA vs. egg-PC-liposome siRNA; p value < 0.05). This evidence concerns the gene PTGS2 and cancer.